Monday, November 20, 2017 3:39:50 PM
Preferred Stock
We are authorized to issue up to 20,000,000 shares of $0.001 par value preferred stock. The board of directors is authorized to designate any series of preferred stock up to the total authorized number of shares.
Series E Preferred Stock
The board of directors has designated 4,350,000 shares of Series E preferred stock. As of the date of this report, there are 1,000,000 shares of Series E preferred stock outstanding. The Series E preferred stock ranks subordinate to the Company’s common stock. The Series E preferred stock is non-redeemable, does not have rights upon liquidation of the Company and does not receive dividends. The outstanding shares of Series E preferred stock have the right to take action by written consent or vote based on the number of votes equal to twice the number of votes of all outstanding shares of common stock. As a result, the holder of Series E preferred stock has 2/3rds of the voting power of all shareholders at any time corporate action requires a vote of shareholders.
Series F Preferred Stock
The board of directors has designated 4,350 shares of Series F convertible preferred stock with a face value of $1.00 per share. As of the date of this report, there are 1,000 shares of Series F convertible preferred stock outstanding. The Series F convertible preferred stock is non-redeemable, does not have rights upon liquidation of the Company, does not have voting rights and does not receive dividends. The holder may, at any time and from time to time convert all, but not less than all. of its shares of Series F convertible preferred stock into a number of fully paid and nonassessable shares of common stock determined by multiplying the number of issued and outstanding shares of common stock of the Company on the date of conversion by three and 45 100ths (3.45). So long as any Series F convertible preferred stock are outstanding, the Company shall not, without first obtaining the approval of the majority of the holders: (a) alter or change the rights, preferences or privileges of any capital stock of the Company so as to affect adversely the Series F convertible preferred stock; (b) create any Senior Securities; (c) create any pari passu Securities; (d) do any act or thing not authorized or contemplated by the Certificate of Designation which would result in any taxation with respect to the Series F convertible preferred stock under Section 305 of the Internal Revenue Code of 1986, as amended, or any comparable provision of the Internal Revenue Code as hereafter from time to time amended, (or otherwise suffer to exist any such taxation as a result thereof).
Series G Preferred Stock
The board of directors has designated 1,000 shares of Series G preferred stock. As of the date of this report, there are no shares of Series G preferred stock outstanding. The Series G preferred stock is does not have voting rights, does not have rights upon liquidation of the Company and does not receive dividends. These shares were created after February 28, 2017.
Recent AITX News
- Shares Moving Up For AI SAAS Firm on News of an Initial Order • AllPennyStocks.com • 04/11/2024 03:47:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/07/2024 11:04:41 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/05/2024 11:08:07 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/04/2024 11:01:50 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/29/2024 11:09:08 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/27/2024 11:07:07 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/20/2024 11:03:17 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/15/2024 11:03:17 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/12/2024 11:05:06 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/08/2024 11:02:46 AM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 02/07/2024 05:15:21 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/05/2024 11:05:50 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 11:02:25 AM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 01/30/2024 09:21:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/29/2024 11:03:58 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/22/2024 11:01:53 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 01/19/2024 09:00:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/17/2024 11:04:22 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 01/16/2024 08:59:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/09/2024 11:05:51 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2024 11:02:41 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/21/2023 11:03:03 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/14/2023 11:03:10 AM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 12/12/2023 08:58:16 PM
VPR Brands LP Reports Record Annual Financial Performance for Fiscal Year 2023 • VPRB • Apr 19, 2024 11:24 AM
Coinllectibles' Subsidiary, Grand Town Development Limited, Acquires Rare Song Dynasty Ceramics Worth Over USD28million • COSG • Apr 18, 2024 8:03 AM
ILUS Provides Form 10-K Filing Update • ILUS • Apr 17, 2024 9:54 AM
Glucotrack Announces Expansion of Its Continuous Glucose Monitoring Technology to Epidural Glucose Monitoring • GCTK • Apr 17, 2024 8:00 AM
Maybacks Global Entertainment To Fire Up 24 New Stations in Louisiana • AHRO • Apr 16, 2024 1:30 PM
Cannabix Technologies Begins Certification of Contactless Alcohol Breathalyzer, Re-Brands product series to Breath Logix • BLOZF • Apr 16, 2024 8:52 AM